ACUTE MYELOGENOUS LEUKEMIA
Clinical trials for ACUTE MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental antibody targets Hard-to-Treat blood cancers in early trial
Disease control TerminatedThis early-stage study tested a new drug, gentulizumab, in 58 adults with acute myeloid leukemia or myelodysplastic syndrome that returned or didn't respond to standard therapy. The drug works by blocking a protein called CD47 on cancer cells, helping the immune system attack the…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Blood cancer transplant study seeks best prep regimen
Disease control TerminatedThis study looked at adults with certain blood cancers (like leukemia) who needed a stem cell transplant. It compared two different drug combinations given before the transplant to see which one better prevented the cancer from coming back. The study was stopped early, but the go…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE3 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated May 11, 2026 20:52 UTC